N-(m-PEG4)-N'-(DBCO-PEG4)-Cy5
Code | Size | Price |
---|
TAR-T18428-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T18428-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N-(m-PEG4)-N'-(DBCO-PEG4)-Cy5 is a polyethylene glycol-based linker utilized for the synthesis of Proteolysis Targeting Chimeras (PROTACs)[1].
CAS:
2107273-76-5
Molecular Weight:
1087.78
Purity:
0.98
SMILES:
[Cl-].O=C(NCCC(=O)N1C=2C=CC=CC2C#CC=3C=CC=CC3C1)CCOCCOCCOCCOCCN4C=5C=CC=CC5C(C4=CC=CC=CC6=[N+](C=7C=CC=CC7C6(C)C)CCOCCOCCOCCOC)(C)C
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562